Novel phenoxyalkylcarboxylic acid derivatives as hypolipidaemic agents
Authors:
- 15 November 2011
- journal article
- other
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 27 (2) , 311-318
Abstract
Novel phenoxyalkylcarboxylic acid derivatives based on the natural scaffolds, flavonoids, or resveratrol were designed, synthesized, and evaluated for hypolipidaemic activity. Among the compounds, 30b lowered the triglycerides by 48.5% (P < 0.05) and total cholesterol by 44.2% (P < 0.05), respectively, and was more effective than the reference drug fenofibric acid in a Triton WR-1339-induced hyperlipidaemic mice model orally (300 mg/kg body weight). 30b also showed 59.4% triglycerides lowering in an alloxan-induced diabetic mice model orally (150 mg/kg body weight). Receptor docking studies revealed that compound 30b could interact with the amino acid residues in the ligand-binding domain essential for the activation of the PPARα. The results indicate that resveratrol should be a better scaffold to derive a new class of hypolipidaemic agents in comparison with a flavonoid scaffold.Keywords
This publication has 33 references indexed in Scilit:
- Design, synthesis, biological evaluation and docking studies of pterostilbene analogs inside PPARαBioorganic & Medicinal Chemistry, 2008
- Substituted 2-[(4-Aminomethyl)phenoxy]-2-methylpropionic Acid PPARα Agonists. 1. Discovery of a Novel Series of Potent HDLc Raising AgentsJournal of Medicinal Chemistry, 2007
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Pterostilbene, a New Agonist for the Peroxisome Proliferator-Activated Receptor α-Isoform, Lowers Plasma Lipoproteins and Cholesterol in Hypercholesterolemic HamstersJournal of Agricultural and Food Chemistry, 2005
- Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statinThe American Journal of Cardiology, 2005
- Design, synthesis, and evaluation of a new class of noncyclic 1,3-dicarbonyl compounds as PPARα selective activatorsBioorganic & Medicinal Chemistry Letters, 2004
- Wine, alcohol, platelets, and the French paradox for coronary heart diseaseThe Lancet, 1992
- The ichthyotoxicity and coronary vasodilator action of 3,3'-dihydroxy-.ALPHA.,.BETA.-diethylstilbene.Chemical and Pharmaceutical Bulletin, 1987
- Effects of stilbenes on arachidonate metabolism in leukocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism.Chemical and Pharmaceutical Bulletin, 1982